Abstract:α-Glucosidase inhibitors, which can inhibit the digestion of carbohydrates into glucose, are one of important groups of anti-type 2 diabetic drugs. In the present study, we report our effort on the discovery and optimization of α-glucosidase inhibitors with tetrahydrobenzo[b]thiophen-2-yl)urea core. Screening of an in-house library revealed a moderated α-glucosidase inhibitors, 5a, and then the following structural optimization was performed to obtain more efficient derivatives. Most of these derivatives showed increased inhibitory activity against α-glucosidase than the parental compound 5a (IC50 of 26.71 ± 1.80 μM) and the positive control acarbose (IC50 of 258.53 ± 1.27 μM). Among them, compounds 8r (IC50 = 0.59 ± 0.02 μM) and 8s (IC50 = 0.65 ± 0.03 μM) were the most potent inhibitors, and showed selectivity over α-amylase. The direct binding of both compounds with α-glucosidase was confirmed by fluorescence quenching experiments. Kinetics study revealed that these compounds were non-competitive inhibitors, which was consistent with the molecular docking results that compounds 8r and 8s showed high preference to bind to the allosteric site instead of the active site of α-glucosidase. In addition, compounds 8r and 8s were not toxic (IC50 > 100 μM) towards LO2 and HepG2 cells. Finally, the in vivo anti-hyperglycaemic activity assay results indicated that compounds 8r could significantly decrease the level of plasma glucose and improve glucose tolerance in SD rats treated with sucrose. The present study provided the tetrahydrobenzo[b]thiophen-2-yl)urea chemotype for developing novel α-glucosidase inhibitors against type 2 diabetes.

Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Synthesis and hypoglycemic activity of sulfonaminothioureas and sulfonamino-cyanoguanidines

Synthesis and Biological Evaluation of Novel Benzyl-Substituted (S)-Phenylalanine Derivatives As Potent Dipeptidyl Peptidase 4 Inhibitors.

[Synthesis and Preliminary Evaluation of Antidiabetic Activity of 4-(3-(4-Bromophenyl)-3-oxo-1-arylpropylamino)-n-(5-methylisoxazol-3-yl)benzenesulfonamide].

Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation

Design, Synthesis and Hypoglycemic Activity of 3-Methyl-1-phenyl-4-{4-[(5-methyl-2-phenyloxazol-4-yl)methoxy]benzylene(benzyl)}-2-pyrazol-5-one

Design, synthesis, molecular dynamic simulation, DFT analysis, computational pharmacology and decoding the antidiabetic molecular mechanism of sulphonamide-thiazolidin-4-one hybrids

Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents

[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives]

Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors

Design, Synthesis and in Vivo Evaluation of Novel C‐Aryl Glucosides As Potent Sodium‐Dependent Glucose Cotransporters Inhibitors for the Treatment of Diabetes

Design, Synthesis And Hypoglycemic Activity Of 3-Methyl-1-Phenyl-4-{4-[(5-Methyl-2-Phenyloxazol-4-Yl)Methoxy] Benzylene(Benzyl)}-2-Pyrazol-5-One

Synthesis and Insulin‐sensitizing Activity of a Series of 2‐benzyl‐1,3‐dicarbonyl Derivatives

Synthesis and hypoglycemia activity of sulfonyl cyanoguanidines

Synthesis and Evaluation of the Α-Glucosidase Inhibitory Activity of 3-[4-(phenylsulfonamido)benzoyl]-2h-1-benzopyran-2-one Derivatives

Synthesis and Preliminary Evaluation of Antidiabetic Activity of 4[3-(4-Bromophenyl)-3-oxo-1-arylpropylamino]benzenesulfonamide

Design, Synthesis and Biological Activity Evaluation of a New Class of 2,4-Thiazolidinedione Compounds As Insulin Enhancers

Design, Synthesis and Biological Evaluation of Novel (E)-2-benzylidene-n-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide Derivatives As Α-Glucosidase Inhibitors.

Synthesis and Biological Evaluation of Azobicyclo[3.3.0] Octane Derivatives As Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Type 2 Diabetes

Synthesis & Alpha-Glucosidase Inhibitory & Glucose Consumption-Promoting Activities O Flavonoid-Coumarin Hybrids